201 related articles for article (PubMed ID: 23660322)
1. [Relationship between macular morphology and visual function in diabetic macular edema].
Jin HY; Liu HY; Liu K; Sun XD; Ren QS; Xu X
Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(7):524-7. PubMed ID: 23660322
[TBL] [Abstract][Full Text] [Related]
2. Diabetic macular edema: correlation between microperimetry and optical coherence tomography findings.
Vujosevic S; Midena E; Pilotto E; Radin PP; Chiesa L; Cavarzeran F
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3044-51. PubMed ID: 16799051
[TBL] [Abstract][Full Text] [Related]
3. [Correlation of retinal sensitivity, visual acuity and central macular thickness in different types of diabetic macular edema].
Yang XL; Zou HD; Xu X
Zhonghua Yan Ke Za Zhi; 2013 Dec; 49(12):1081-8. PubMed ID: 24499694
[TBL] [Abstract][Full Text] [Related]
4. Correlation of retinal sensitivity measured with fundus-related microperimetry to visual acuity and retinal thickness in eyes with diabetic macular edema.
Okada K; Yamamoto S; Mizunoya S; Hoshino A; Arai M; Takatsuna Y
Eye (Lond); 2006 Jul; 20(7):805-9. PubMed ID: 16021181
[TBL] [Abstract][Full Text] [Related]
5. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation.
Vujosevic S; Bottega E; Casciano M; Pilotto E; Convento E; Midena E
Retina; 2010 Jun; 30(6):908-16. PubMed ID: 20168272
[TBL] [Abstract][Full Text] [Related]
6. Diabetic macular edema: fundus autofluorescence and functional correlations.
Vujosevic S; Casciano M; Pilotto E; Boccassini B; Varano M; Midena E
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):442-8. PubMed ID: 20720226
[TBL] [Abstract][Full Text] [Related]
7. The correlation between optical coherence tomographic features and severity of retinopathy, macular thickness and visual acuity in diabetic macular edema.
Alkuraya H; Kangave D; Abu El-Asrar AM
Int Ophthalmol; 2005 Jun; 26(3):93-9. PubMed ID: 17063373
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of intravitreal triamcinolone acetonide in long standing diabetic macular edema: a microperimetry and optical coherence tomography study.
Grenga P; Lupo S; Domanico D; Vingolo EM
Retina; 2008 Oct; 28(9):1270-5. PubMed ID: 18664938
[TBL] [Abstract][Full Text] [Related]
9. Temporal variation in diabetic macular edema measured by optical coherence tomography.
Frank RN; Schulz L; Abe K; Iezzi R
Ophthalmology; 2004 Feb; 111(2):211-7. PubMed ID: 15019364
[TBL] [Abstract][Full Text] [Related]
10. Correlation between ganglion cell layer thinning and poor visual function after resolution of diabetic macular edema.
Bonnin S; Tadayoni R; Erginay A; Massin P; Dupas B
Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):978-82. PubMed ID: 25574055
[TBL] [Abstract][Full Text] [Related]
11. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
[TBL] [Abstract][Full Text] [Related]
12. Central retinal thickness measured with HD-OCT shows a weak correlation with visual acuity in eyes with CSME.
Nunes S; Pereira I; Santos A; Bernardes R; Cunha-Vaz J
Br J Ophthalmol; 2010 Sep; 94(9):1201-4. PubMed ID: 20530184
[TBL] [Abstract][Full Text] [Related]
13. Enhanced depth imaging optical coherence tomography in type 2 diabetes.
Querques G; Lattanzio R; Querques L; Del Turco C; Forte R; Pierro L; Souied EH; Bandello F
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6017-24. PubMed ID: 22879414
[TBL] [Abstract][Full Text] [Related]
14. Retina rejuvenation therapy for diabetic macular edema: a pilot study.
Pelosini L; Hamilton R; Mohamed M; Hamilton AM; Marshall J
Retina; 2013 Mar; 33(3):548-58. PubMed ID: 23023529
[TBL] [Abstract][Full Text] [Related]
15. Panretinal photocoagulation combined with intravitreal bevacizumab in high-risk proliferative diabetic retinopathy.
Cho WB; Oh SB; Moon JW; Kim HC
Retina; 2009 Apr; 29(4):516-22. PubMed ID: 19262436
[TBL] [Abstract][Full Text] [Related]
16. [Evaluate the effectiveness of laser therapy in the treatment of diabetic maculopathy].
Mrugacz M; Krajewska M; Bryl A; Szuszkiewicz M
Pol Merkur Lekarski; 2013 Jun; 34(204):351-4. PubMed ID: 23882935
[TBL] [Abstract][Full Text] [Related]
17. Characterization of macular edema from various etiologies by optical coherence tomography.
Catier A; Tadayoni R; Paques M; Erginay A; Haouchine B; Gaudric A; Massin P
Am J Ophthalmol; 2005 Aug; 140(2):200-6. PubMed ID: 15992752
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
[TBL] [Abstract][Full Text] [Related]
19. [Triamcinolone in the treatment of the diabetic macular edema--one-year results].
Dusová J; Studnicka J; Rencová E; Korda V; Hejcmanová D
Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654
[TBL] [Abstract][Full Text] [Related]
20. Three different phenotypes of mild nonproliferative diabetic retinopathy with different risks for development of clinically significant macular edema.
Nunes S; Ribeiro L; Lobo C; Cunha-Vaz J
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4595-604. PubMed ID: 23745006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
